,i #aahth ,,congress #ast ,session ,h4 ,r4 #ebei ,,in ,,the ,,house ,,of ,,representatives ,august #bb1 #bjbc,ms4 ,slotkin 7for herself1 ,mr4 ,posey1 and ,mr4 ,turner7 introduced the following bill2 which was referred to the ,committee on ,armed ,services ,a ,,bill ,to direct the ,secretary of ,defense to include in periodic health assessments of members of the ,armed ,forces an evaluation of whether the member has been exposed to perfluoroalkyl substances and polyfluoroalkyl substances1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,,pfas ,exposure ,assessment and ,documentation ,act4 #b4 ,inclusion of exposure to perfluoroalkyl and polyfluoroalkyl substances as part of periodic health assessments 7a7 ,periodic health assessment ,the ,secretary of ,defense shall ensure that any periodic health assessment provided to a member of the ,armed ,forces includes an evaluation of whether the member has been-- 7#a7 based or stationed at a military installation identified by the ,department of ,defense as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation2 or 7#b7 exposed to such substances1 including by evaluating any information in the health record of the member4 7b7 ,separation history and physical examinations ,section #aade7;a77#e7 of title #aj1 ,united ,states ,code1 is amended by adding at the end the following new subparagraph3 7,d7 ,the ,secretary concerned shall ensure that each physical examination of a member under subparagraph 7,a7 includes an assessment of whether the member was-- 7i7 based or stationed at a military installation identified by the ,department as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation2 or 7ii7 exposed to such substances1 including by assessing any information in the health record of the member4 4 7c7 ,deployment assessments ,section #ajgd;f7b77#b7 of title #aj1 ,united ,states ,code1 is amended by adding at the end the following new subparagraph3 7,e7 ,an assessment of whether the member was-- 7i7 based or stationed at a military installation identified by the ,department as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the military installation2 or 7ii7 exposed to such substances1 including by assessing any information in the health record of the member4 4 #c4 ,provision of blood testing for members of the ,armed ,forces1 former members of the ,armed ,forces1 and their families to determine exposure to perfluoroalkyl substances or polyfluoroalkyl substances 7a7 ,members of the ,armed ,forces 7#a7 ,in general ,if a covered evaluation of a member of the ,armed ,forces results in a positive determination of potential exposure to perfluoroalkyl substances or polyfluoroalkyl substances1 the ,secretary of ,defense shall provide to that member1 during that covered evaluation1 blood testing to determine and document potential exposure to such substances4 7#b7 ,inclusion in health record ,the results of blood testing of a member of the ,armed ,forces conducted under paragraph 7#a7 shall be included in the health record of the member4 7b7 ,former members of the ,armed ,forces and family members ,the ,secretary shall pay for blood testing to determine and document potential exposure to perfluoroalkyl substances or polyfluoroalkyl substances for any covered individual1 at the election of the individual1 either through the ,,tricare program for individuals otherwise eligible for such program or through the use of vouchers to obtain such testing4 7c7 ,definitions ,in this section3 7#a7 ,the term covered evaluation means-- 7,a7 a periodic health assessment conducted in accordance with section #b7;a72 7,b7 a separation history and physical examination conducted under section #aade7;a77#e7 of title #aj1 ,united ,states ,code1 as amended by section #b7;b72 and 7,c7 a deployment assessment conducted under section #ajgd;f7b77#b7 of such title1 as amended by section #b7;c74 7#b7 ,the term covered individual means a former member of the ,armed ,forces or a family member of a member or former member of the ,armed ,forces who lived at a location 7or the surrounding area of such a location7 identified by the ,department of ,defense as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the individual lived at that location 7or surrounding area74 7#c7 ,the term ,,tricare program has the meaning given that term in section #ajgb7g7 of title #aj1 ,united ,states ,code4 #d4 ,documentation of exposure to perfluoroalkyl substances or polyfluoroalkyl substances 7a7 ,sharing of information ,the ,secretary of ,defense and the ,secretary of ,veterans ,affairs shall enter into a memorandum of understanding providing for the sharing by the ,department of ,defense with the ,department of ,veterans ,affairs of the results of covered evaluations regarding the exposure by a member of the ,armed ,forces to perfluoroalkyl substances or polyfluoroalkyl substances4 7b7 ,registry 7#a7 ,establishment ,the ,secretary of ,defense shall establish a registry of members of the ,armed ,forces who have been exposed to1 or are suspected to have been exposed to1 perfluoroalkyl substances or polyfluoroalkyl substances4 7#b7 ,inclusion in registry ,the ,secretary shall include a member of the ,armed ,forces in the registry established under paragraph 7#a7 if a covered evaluation of the member establishes that the member-- 7,a7 was based or stationed at a location identified by the ,department of ,defense as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the location2 or 7,b7 was exposed to such substances4 7#c7 ,blood testing ,the results of any blood test conducted under section #c7;a7 shall be included in the registry established under paragraph 7#a7 for any member of the ,armed ,forces included in the registry4 7#d7 ,election ,a member of the ,armed ,forces may elect not to be included in the registry established under paragraph 7#a74 7c7 ,provision of information ,the ,secretary of ,defense shall provide to a member of the ,armed ,forces more information on perfluoroalkyl substances and polyfluoroalkyl substances and the potential impact of exposure to such substances if a covered evaluation of such member establishes that the member-- 7#a7 was based or stationed at a location identified by the ,department of ,defense as a location with a known or suspected release of perfluoroalkyl substances or polyfluoroalkyl substances during the period in which the member was based or stationed at the location2 or 7#b7 was exposed to such substances4 7d7 ,rule of construction ,nothing in this section may be construed to preclude eligibility of a veteran for benefits under the laws administered by the ,secretary of ,veterans ,affairs by reason of the exposure of the veteran to perfluoroalkyl substances or polyfluoroalkyl substances not being recorded in a covered evaluation4 7e7 ,covered evaluation defined ,in this section1 the term covered evaluation means-- 7#a7 a periodic health assessment conducted in accordance with section #b7;a72 7#b7 a separation history and physical examination conducted under section #aade7;a77#e7 of title #aj1 ,united ,states ,code1 as amended by section #b7;b72 and 7#c7 a deployment assessment conducted under section #ajgd;f7b77#b7 of such title1 as amended by section #b7;c74